A portion of the first and second authors' time was supported by grant no. 2838 from the Crohn's and Colitis Foundation of America, and a portion of this project was funded by a Children's Research Institute Pilot Innovation Research Award.
Identifying youth nonadherence in clinical settings: Data-based recommendations for children and adolescents with inflammatory bowel disease†
Article first published online: 29 AUG 2011
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 18, Issue 7, pages 1254–1259, July 2012
How to Cite
Greenley, R. N., Kunz, J. H., Biank, V., Martinez, A., Miranda, A., Noe, J., Telega, G., Tipnis, N. A., Werlin, S. and Stephens, M. C. (2012), Identifying youth nonadherence in clinical settings: Data-based recommendations for children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis, 18: 1254–1259. doi: 10.1002/ibd.21859
- Issue published online: 11 JUN 2012
- Article first published online: 29 AUG 2011
- Manuscript Accepted: 18 JUL 2011
- Manuscript Received: 11 JUL 2011
- compliance issues in IBD;
- psychosocial aspects of IBD
To examine the validity of patient self-report of thiopurine adherence in pediatric inflammatory bowel disease (IBD) against an objective electronic monitoring adherence measure, and to investigate the role of youth and maternal involvement in remembering to take daily medications as predictors of medication adherence.
Fifty-one youths with IBD, ages 11–18 years, participated. Youths completed questionnaire assessments of their own and their maternal caregiver's involvement in remembering to take daily medications at baseline, completed monthly interviews assessing thiopurine adherence over the past week for a period of 6 months, and utilized a Medication Events Monitoring System (MEMS) electronic monitor for their thiopurine medication for 6 months. Participants were grouped into adherent (at least 80% of doses taken based on objective MEMS caps) or nonadherent for analyses.
Youths who were nonadherent based on electronic monitoring overestimated their adherence by 23%, whereas adherent youths overestimated their adherence by only 2%, and as such patient self-report offered little utility in identifying youths who were nonadherent. Youths who reported high levels of involvement in remembering to take their medications were nearly eight times less likely to be nonadherent.
The current findings provide evidence that clinicians who work with children and adolescents with IBD may benefit from modifying their approach to nonadherence screening. Asking about youth involvement in remembering daily medications may be more informative than asking them to recall their medication-taking behavior over the last week in identifying those at highest risk for nonadherence. (Inflamm Bowel Dis 2011;)